Cargando…

Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease with exacerbations causing hospitalizations, morbidity, and mortality. COPD exacerbation causes a substantial health impact, and its subtypes might differ in prognosis and treatment response. METHODS: This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yao-Kuang, Su, Wen-Lin, Yang, Mei-Chen, Chen, Sin-Yi, Wu, Chih-Wei, Lan, Chou-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416186/
https://www.ncbi.nlm.nih.gov/pubmed/34511892
http://dx.doi.org/10.2147/COPD.S317177
_version_ 1783748127729123328
author Wu, Yao-Kuang
Su, Wen-Lin
Yang, Mei-Chen
Chen, Sin-Yi
Wu, Chih-Wei
Lan, Chou-Chin
author_facet Wu, Yao-Kuang
Su, Wen-Lin
Yang, Mei-Chen
Chen, Sin-Yi
Wu, Chih-Wei
Lan, Chou-Chin
author_sort Wu, Yao-Kuang
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease with exacerbations causing hospitalizations, morbidity, and mortality. COPD exacerbation causes a substantial health impact, and its subtypes might differ in prognosis and treatment response. METHODS: This study evaluated the factors of COPD exacerbations and explored the probabilities of frequent severe COPD exacerbations. Categorical and continuous variables between groups were compared. The hazard ratio (HR) and the probability of no hospital readmission were also estimated. RESULTS: A total of 617 COPD patients were enrolled and comprised the frequent exacerbator (N = 226) and the non-frequent exacerbator (N = 391) groups. The frequent exacerbator group significantly displayed a higher eosinophil count (EC; p=0.004), a higher percentage of the frequent severe acute exacerbation history before the index hospitalization (IH; p < 0.001), a lower FEV1 value (p=0.001), and a higher triple combination inhaler prior and following the IH (p < 0.001 and p=0.002) than the non-frequent exacerbator one. Increasing age (aOR of 1.02), higher EC (aOR of 1.09), and lower FEV1 value (aOR of 0.72) were significantly associated with an increased hospital readmission risk. The readmission rate and risk were higher in patients with a history of frequent severe acute exacerbation (aHR of 3.38) than those without severe acute exacerbation. Cases treated with the triple combination inhaler before the IH had a higher readmission rate and risk than non-users. CONCLUSION: Patients with EC ≥2%, FEV1 <50%, or frequent severe acute exacerbation history before the IH have a higher risk of being diagnosed with a frequent exacerbator phenotype. Besides, higher age, triple combination inhaler before the IH, and smoking might be independently correlated with the frequent readmission risk within 1-year post-exacerbation. A better comprehension of the COPD exacerbation mechanism may further identify the best course of preventative strategy and lead to novel interventions.
format Online
Article
Text
id pubmed-8416186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84161862021-09-09 Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients Wu, Yao-Kuang Su, Wen-Lin Yang, Mei-Chen Chen, Sin-Yi Wu, Chih-Wei Lan, Chou-Chin Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease with exacerbations causing hospitalizations, morbidity, and mortality. COPD exacerbation causes a substantial health impact, and its subtypes might differ in prognosis and treatment response. METHODS: This study evaluated the factors of COPD exacerbations and explored the probabilities of frequent severe COPD exacerbations. Categorical and continuous variables between groups were compared. The hazard ratio (HR) and the probability of no hospital readmission were also estimated. RESULTS: A total of 617 COPD patients were enrolled and comprised the frequent exacerbator (N = 226) and the non-frequent exacerbator (N = 391) groups. The frequent exacerbator group significantly displayed a higher eosinophil count (EC; p=0.004), a higher percentage of the frequent severe acute exacerbation history before the index hospitalization (IH; p < 0.001), a lower FEV1 value (p=0.001), and a higher triple combination inhaler prior and following the IH (p < 0.001 and p=0.002) than the non-frequent exacerbator one. Increasing age (aOR of 1.02), higher EC (aOR of 1.09), and lower FEV1 value (aOR of 0.72) were significantly associated with an increased hospital readmission risk. The readmission rate and risk were higher in patients with a history of frequent severe acute exacerbation (aHR of 3.38) than those without severe acute exacerbation. Cases treated with the triple combination inhaler before the IH had a higher readmission rate and risk than non-users. CONCLUSION: Patients with EC ≥2%, FEV1 <50%, or frequent severe acute exacerbation history before the IH have a higher risk of being diagnosed with a frequent exacerbator phenotype. Besides, higher age, triple combination inhaler before the IH, and smoking might be independently correlated with the frequent readmission risk within 1-year post-exacerbation. A better comprehension of the COPD exacerbation mechanism may further identify the best course of preventative strategy and lead to novel interventions. Dove 2021-08-30 /pmc/articles/PMC8416186/ /pubmed/34511892 http://dx.doi.org/10.2147/COPD.S317177 Text en © 2021 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wu, Yao-Kuang
Su, Wen-Lin
Yang, Mei-Chen
Chen, Sin-Yi
Wu, Chih-Wei
Lan, Chou-Chin
Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
title Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
title_full Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
title_fullStr Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
title_full_unstemmed Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
title_short Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
title_sort characterization associated with the frequent severe exacerbator phenotype in copd patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416186/
https://www.ncbi.nlm.nih.gov/pubmed/34511892
http://dx.doi.org/10.2147/COPD.S317177
work_keys_str_mv AT wuyaokuang characterizationassociatedwiththefrequentsevereexacerbatorphenotypeincopdpatients
AT suwenlin characterizationassociatedwiththefrequentsevereexacerbatorphenotypeincopdpatients
AT yangmeichen characterizationassociatedwiththefrequentsevereexacerbatorphenotypeincopdpatients
AT chensinyi characterizationassociatedwiththefrequentsevereexacerbatorphenotypeincopdpatients
AT wuchihwei characterizationassociatedwiththefrequentsevereexacerbatorphenotypeincopdpatients
AT lanchouchin characterizationassociatedwiththefrequentsevereexacerbatorphenotypeincopdpatients